Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Henan Shijia Photons Technology
688313
5
Shenzhen Zesum Technology
301486
CN Stock MarketDetailed Quotes
002365 Qianjiang Yongan Pharmaceutical
- 12.50
- +0.12+0.97%
Trading Apr 25 14:06 CST
3.68BMarket Cap59.52P/E (TTM)
13.62High11.91Low890.55KlotVolume13.60Open12.38Pre Close1.18BTurnover36.27%Turnover Ratio59.52P/E (Static)294.68MShares13.6252wk High1.85P/B3.07BFloat Cap6.6652wk Low13.62Limit Up245.56MShs Float28.37Historical High11.14Limit Down13.81%Amplitude4.11Historical Low0.10Dividend TTM13.21Avg Price540.35KlotAsk0.80%Div YieldTTM100Lot Size283.96KlotBid
Qianjiang Yongan Pharmaceutical Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -12.72%868.38M | -22.18%658.7M | -34.29%427.11M | -33.56%183.76M | -36.00%994.88M | -31.50%846.49M | -21.16%649.99M | -28.20%276.58M | 11.01%1.55B | 27.79%1.24B |
| Refunds of taxes and levies | -17.58%28.71M | -22.95%21.85M | -38.00%13.65M | -28.55%9.14M | -29.17%34.84M | -27.12%28.35M | -29.09%22.01M | 20.55%12.79M | 43.95%49.18M | 67.73%38.91M |
| Cash received relating to other operating activities | -49.83%9.66M | -28.75%47.64M | 68.22%11.9M | 1,125.56%148.03M | -79.97%19.26M | -37.57%66.86M | -91.84%7.08M | -86.46%12.08M | 853.80%96.14M | 786.43%107.09M |
| Cash inflows from operating activities | -13.56%906.75M | -22.67%728.19M | -33.34%452.66M | 13.10%340.93M | -38.29%1.05B | -31.85%941.7M | -27.93%679.07M | -37.84%301.45M | 17.67%1.7B | 37.86%1.38B |
| Goods services cash paid | -4.37%571.57M | -16.56%454.54M | -24.36%296.36M | -20.40%136.77M | -36.68%597.7M | -31.66%544.75M | -32.84%391.78M | -36.23%171.83M | -15.76%943.95M | 4.21%797.09M |
| Staff behalf paid | -17.69%112.71M | -20.66%87.82M | -20.17%63.9M | -22.92%40.09M | 3.73%136.94M | 3.89%110.69M | 5.48%80.04M | -0.19%52.01M | 15.05%132.01M | 27.22%106.54M |
| All taxes paid | 18.20%38.84M | 125.27%35.19M | 299.57%29.39M | 60.01%8.33M | -37.25%32.86M | -63.10%15.62M | -66.20%7.36M | -49.40%5.21M | 42.89%52.37M | 35.18%42.33M |
| Cash paid relating to other operating activities | 29.26%77.91M | -24.79%57.35M | -22.68%31.53M | 569.29%160.64M | -67.28%60.28M | -54.21%76.24M | -67.88%40.78M | -81.10%24M | 160.11%184.2M | 52.54%166.52M |
| Cash outflows from operating activities | -3.23%801.04M | -15.04%634.89M | -19.00%421.18M | 36.67%345.83M | -36.93%827.78M | -32.83%747.3M | -35.65%519.96M | -44.85%253.04M | -2.25%1.31B | 12.47%1.11B |
| Net cash flows from operating activities | -52.21%105.71M | -52.01%93.29M | -80.21%31.48M | -110.13%-4.9M | -42.88%221.2M | -27.82%194.4M | 18.58%159.11M | 85.05%48.41M | 280.39%387.28M | 1,936.77%269.34M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 20.93%1.68B | -9.30%913.36M | -5.40%618.98M | -36.10%188.76M | 38.99%1.39B | 64.16%1.01B | 76.92%654.31M | 43.23%295.38M | 8.31%1B | -17.36%613.46M |
| Cash received from returns on investments | 53.10%35.31M | 45.83%23.74M | 95.37%14.42M | 62.49%5.2M | -14.51%23.06M | -14.71%16.28M | -40.48%7.38M | -58.88%3.2M | 47.07%26.98M | 37.99%19.09M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 128.55%1.89M | 42.39%1.17M | -72.48%226.94K | -28.24%215.27K | 115.67%828.47K | -43.57%824.63K | -43.57%824.63K | -59.17%300K | -23.03%384.13K | 403.95%1.46M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | --125.02K | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | --45.21M | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 17.75%1.72B | -8.38%938.27M | -4.36%633.62M | -35.03%194.18M | 42.02%1.46B | 61.53%1.02B | 72.67%662.51M | 39.18%298.88M | 9.04%1.03B | -16.19%634.01M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -2.23%118.04M | 22.08%89.76M | 15.44%62M | -4.72%33.33M | -19.01%120.74M | -9.13%73.52M | 51.45%53.71M | 156.76%34.98M | 136.44%149.07M | 115.21%80.91M |
| Cash paid to acquire investments | 11.22%1.65B | -11.19%986.87M | -16.13%639.65M | -38.21%216.82M | 33.63%1.48B | 38.31%1.11B | 117.96%762.63M | 136.28%350.89M | 34.92%1.11B | 36.12%803.44M |
| Cash paid relating to other investing activities | ---- | --7.5M | --7.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 10.21%1.77B | -8.50%1.08B | -13.13%709.15M | -35.17%250.15M | 27.40%1.6B | 33.97%1.18B | 111.84%816.34M | 138.00%385.87M | 36.61%1.26B | 40.85%884.35M |
| Net cash flows from investing activities | 66.86%-47.38M | 9.21%-145.86M | 50.90%-75.53M | 35.65%-55.98M | 37.94%-142.99M | 35.83%-160.65M | -9,131.53%-153.83M | -265.33%-86.99M | -1,155.56%-230.4M | -294.62%-250.34M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --499K | --1M |
| Cash from borrowing | 300.00%40M | 106.00%20.6M | 106.00%20.6M | --600K | -83.33%10M | -66.67%10M | -66.67%10M | ---- | 100.00%60M | 50.00%30M |
| Cash received relating to other financing activities | --600K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 306.00%40.6M | 106.00%20.6M | 106.00%20.6M | --600K | -83.47%10M | -67.74%10M | -66.67%10M | ---- | 59.88%60.5M | 25.00%31M |
| Borrowing repayment | -73.75%10.5M | -75.00%10M | -75.00%10M | ---- | 0.00%40M | 0.00%40M | 0.00%40M | 200.00%30M | -69.78%40M | -70.22%40M |
| Dividend interest payment | 0.12%35.82M | 10.62%41.14M | 7,164.18%9.41M | 7,271.12%6.1M | 1,232.02%35.77M | 2,392.28%37.19M | -92.23%129.5K | -92.62%82.71K | -91.59%2.69M | -95.19%1.49M |
| -Including:Cash payments for dividends or profit to minority shareholders | --6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.82%1.12M | -5.82%1.12M |
| Cash payments relating to other financing activities | --31.68M | --24.18M | --13.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from financing activities | 2.94%78M | -2.42%75.32M | -18.67%32.64M | -79.73%6.1M | 77.51%75.77M | 86.04%77.19M | -3.69%40.13M | 170.50%30.08M | -75.90%42.69M | -74.90%41.49M |
| Net cash flows from financing activities | 43.14%-37.4M | 18.56%-54.72M | 60.05%-12.04M | 81.73%-5.5M | -469.23%-65.77M | -540.38%-67.19M | -158.26%-30.13M | -438.82%-30.08M | 112.79%17.81M | 92.53%-10.49M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -25.86%5.25M | 36.82%6.21M | -12.60%3.9M | 264.73%2.1M | 8.71%7.08M | -34.74%4.54M | 26.16%4.46M | -4,711.89%-1.27M | 701.77%6.51M | 4,602.12%6.95M |
| Net increase in cash and cash equivalents | 34.15%26.18M | -249.67%-101.08M | -155.99%-52.19M | 8.09%-64.28M | -89.23%19.51M | -287.00%-28.91M | -116.39%-20.39M | -179.77%-69.94M | 1,185.70%181.21M | 1,217.64%15.46M |
| Add:Begin period cash and cash equivalents | 7.10%294.23M | 7.11%294.23M | 7.10%294.23M | 7.11%294.23M | 193.79%274.71M | 193.78%274.7M | 193.79%274.71M | 193.78%274.7M | -15.15%93.51M | -15.15%93.51M |
| End period cash equivalent | 8.90%320.41M | -21.42%193.15M | -4.83%242.04M | 12.30%229.95M | 7.10%294.23M | 125.58%245.8M | 16.72%254.33M | 13.01%204.76M | 193.79%274.71M | -2.16%108.96M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs